Grading and Follow-Up of T Lymphocyte-Mediated Acute Interstitial Nephritis Following Checkpoint Inhibitor Therapy

Files

Authors

Ping L. Zhang, Corewell Health
Wei Li, Corewell Health
Hassan D. Kanaan, Corewell Health

Description

Immuno-check point inhibitors (CPI) such as PD-1/PD-L1 inhibitors have been used to treat a variety of metastatic carcinoma with positive effects. However, there are complications such as gastrointestinal, hepatic and endocrine symptoms and kidney dysfunction. We describe our experience with CPI-associated acute interstitial nephritis (AIN).

Publication Date

10-2024

Disciplines

Pathology

Recommended Citation

Zhang PL, Li W, Kanaan HD. Grading and follow-up of t lymphocyte-mediated acute interstitial nephritis following checkpoint inhibitor therapy. Presented at: American Society of Nephrology (ASN) Kidney Week; 2024; Oct 23-27; San Diego CA.

Comments

American Society of Nephrology (ASN) Kidney Week, October 23-27, 2024, San Diego CA.